Skip to main contentSkip to navigation
Sirius Investors
Healixa Inc

Healixa Inc

EMOR
OTCTechnology

Healixa Inc (EMOR) Investment Research Dashboard

About Healixa Inc (EMOR) stock analysis

Get live EMOR stock price $0.03, comprehensive Healixa Inc stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time EMOR stock data and investment insights.

0.03
6.26%Today
Market Cap
26.19M
Volume
22.20K
52W High
0.07
52W Low
0.01

Loading chart data...

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Healixa Inc. operates as a technology company with assets in both healthtech and fintech. It offers tech solutions to enterprise partner channels across a range of industries, including employer benefits, travel, pharma, logistics, and other. Healixa...

Company Information

CEO
Ian Parker
Sector
Technology
Industry
Software - Application
Employees
26

Contact Information

Address
331 Dante Court
Country
US

Investment Analysis & Business Insights

Technology
Software - Application

Investment Highlights

Strong presence in the Technology sector with established market position

Lower volatility stock (Beta: 0.16) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Healixa Inc shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Technology may affect company performance
  • Past performance does not guarantee future results for Healixa Inc
  • Investors should consider how Healixa Inc fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

26.19M

P/E Ratio (TTM)

-100.47

Beta

0.16

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Technology Sector

The Technology sector includes companies that develop and provide technology products and services, including software, hardware, and digital solutions.

Technology (1D)

17/100

Overall
+0.6%
NYSE
+1.5%
NASDAQ
-0.3%
Sector1D1W1MP/EScore
Financial Services+2.2%+5.7%+6.1%19.3
98/100⭐⭐⭐⭐⭐
Communication Services+1.4%+2.9%+4.3%22.2
86/100⭐⭐⭐⭐⭐
Healthcare+0.7%+3.3%+3.5%24.1
80/100⭐⭐⭐⭐⭐
Basic Materials+0.4%+1.1%-0.2%25.2
56/100⭐⭐⭐⭐
Consumer Defensive-0.2%+1.7%+1.2%29.7
56/100⭐⭐⭐⭐
Real Estate-0.5%-0.1%-1.6%29.2
43/100⭐⭐⭐
Energy-2.1%-5.8%-5.1%19.1
39/100⭐⭐
Utilities-1.0%-3.0%-5.9%26.8
28/100⭐⭐
Industrials+0.6%+1.7%-11.2%30.1
26/100⭐⭐
Consumer Cyclical+0.5%-0.4%-6.3%43.0
21/100
Technology+0.6%-2.3%-9.6%40.7
17/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.